Bayer AG

FRA:BAY ISIN:DE0005752000

Bayer AG (FRA:BAY)(ADR:BAYRY) is the management holding company for the Bayer Group. The Company’s business operations are organized into three groups: Bayer HealthCare, which is involved in the research, development and manufacture of health products for people and animals; Bayer CropScience, which is engaged in the crop protection and non-agricultural pest control, and Bayer MaterialScience, which supplies high-performance materials, such as polycarbonates and polyurethanes, and system solutions such as coatings, for a range of everyday uses. In November 2007, the Company suspended worldwide marketing of Trasylol. In October 2008, Bayer AG said that it had launched its new anticoagulant pill Xarelto in Britain and Germany. 


Bayer AG (FRA:BAY) Advances in Renal Cancer Journalists Award

🕔1/16/2009 8:41:38 PM 1031

Bayer HealthCare and the Association of German Medical Journalists (VDMJ) have jointly announced the 2009 Advances in Renal Cancer Journalists' Award Europe, which will honor journalists who have dealt with the issue of renal cancer in a critical and objective manner. The award, endowed with EUR7,500, is donated by Bayer HealthCare. Eligible for the award are printed media, radio, television and film reports.

Read Full Article


  • This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 10) (Since Published: 1648) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • None 
  • Homepage